Enma Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2004.
2004 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Enma Pharmaceuticals Private Limited

Enma Pharmaceuticals Private Limited, a active private limited company, was established on 27 April 2004 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397TN2004PTC053088. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.

It upholds a compliant status. Employing 12 professional, Its leadership includes Merybal Balasingh Barnabas (Additional Director), Nivetha Immanuel (Additional Director), Malini Merybal (Additional Director). Past directors included Thomas Sathiyanathan, Merybal Balasingh Barnabas, Anthonyswamy Simonhercules. It holds ₹3.60 M open charges and ₹1.78 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Old No: 98/06, New No: 52/06, T- Block, (2Nd Floor), 3Rd Avenue, Annanagar West, ,, Chennai, Tamil Nadu, 600040.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397TN2004PTC053088

  • Registration Number

    053088

  • Incorporation Date

    27 April 2004

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹2.00 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 21 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 3.60 M
  • Satisfied Charges ₹ 1.78 Cr
  • Revenue Growth **** -11.18%
  • Profit Growth **** 20.95%
  • Ebitda **** -7.68%
  • Net Worth 15.21%
  • Total Assets **** 6.97%
Company report

Enma Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Enma Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Enma Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Merybal Balasingh Barnabas Additional Director 16 Apr 2022 Current
Nivetha Immanuel Additional Director 09 Dec 2019 Current
Malini Merybal Additional Director 31 Mar 2017 Current
Rajalingam Vaithilingam Director 12 Sep 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 03 Aug 2007 Past
Pramod Abcsdd Managing Director 11 Jan 2016 Past
Pramod Abcsdd Director 01 Dec 2012 Past
Pramod Abcsdd Additional Director 30 Sep 2014 Past
Pramod Abcsdd Director 18 Jan 2014 Past
Pramod Abcsdd Additional Director 30 Sep 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Enma Pharmaceuticals.

Enma Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 11.18% decrease. The company also saw a substantial improvement in profitability, with a 20.95% increase in profit. The company's net worth Soared by an impressive increase of 15.21%.

Enma Pharmaceuticals revenue growth over time
Enma Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -11.18%
*******
*******
*******
*******
Revenue from Operations
*******
 -11.68%
*******
*******
*******
*******
Total Assets
*******
 6.97%
*******
*******
*******
*******
Profit or Loss
*******
 20.95%
*******
*******
*******
*******
Net Worth
*******
 15.21%
*******
*******
*******
*******
EBITDA
*******
 -7.68%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Enma Pharmaceuticals?

In 2021, Enma Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,600,000.00

Satisfied Charges

₹17,800,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 0.36 Cr
Latest Charge Details
Date Lender Amount Status
25 Sep 2021 Axis Bank Limited ₹3.60 M Open
11 Jun 2020 Tamilnad Mercantile Bank Limited ₹1.30 M Satisfied
14 Feb 2019 Tamilnad Mercantile Bank Limited ₹6.50 M Satisfied
30 Jun 2015 The Karur Vysya Bank Limited ₹4.90 M Satisfied
12 Jan 2011 Tamilnad Mercantile Bank Limited ₹0.60 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Enma Pharmaceuticals?

Enma Pharmaceuticals has a workforce of 12 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Enma Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enma Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Enma Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Enma Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Enma Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was completed.

  • Director Appointment

    Progress on Merybal Balasingh Barnabas was appointed as a Additional Director was appointed as a Additional Director on 16 Apr 2022 & has been associated with this company since 3 years 10 months . was documented.

  • Charges

    A charge registered on 11 Jun 2020 via Charge ID 100346290 with Tamilnad Mercantile Bank Limited was fully satisfied on 06 Nov 2021. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 14 Feb 2019 via Charge ID 100243647 with Tamilnad Mercantile Bank Limited was fully satisfied on 06 Nov 2021. was documented.

  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 0.36 Cr with Charge ID 100487808 was registered on 25 Sep 2021. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Enma Pharmaceuticals Private Limited?

The CIN of Enma Pharmaceuticals Private Limited is U51397TN2004PTC053088.

Where is Enma Pharmaceuticals Private Limited headquartered?

Enma Pharmaceuticals Private Limited is headquartered at Old No: 98/06, New No: 52/06, T- Block, (2Nd Floor), 3Rd Avenue, Annanagar West, ,, Chennai, Tamil Nadu, 600040.

When was Enma Pharmaceuticals Private Limited incorporated?

Enma Pharmaceuticals Private Limited was incorporated on 27 April 2004.

Who are the current directors of Enma Pharmaceuticals Private Limited?

The current directors of Enma Pharmaceuticals Private Limited are

What is the primary industry of Enma Pharmaceuticals Private Limited?

The primary industry of Enma Pharmaceuticals Private Limited is Trade.

Is Enma Pharmaceuticals Private Limited a listed company?

Enma Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Enma Pharmaceuticals Private Limited?

The authorized capital of Enma Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.

What is the compliance status of Enma Pharmaceuticals Private Limited?

The compliance status of Enma Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available